tiprankstipranks
Argenx price target raised to $675 from $646 at Oppenheimer
PremiumThe FlyArgenx price target raised to $675 from $646 at Oppenheimer
1M ago
Argenx may have first targeted myositis treatment, says H.C. Wainwright
Premium
The Fly
Argenx may have first targeted myositis treatment, says H.C. Wainwright
1M ago
Argenx to continue development of efgartigimod subcutaneous
Premium
The Fly
Argenx to continue development of efgartigimod subcutaneous
1M ago
Zai Lab, Argenx announce China NMPA approval for Vyvgart Hytrulo sBLA
PremiumThe FlyZai Lab, Argenx announce China NMPA approval for Vyvgart Hytrulo sBLA
2M ago
Scotiabank upgrades Argenx on Vyvgart upside, pipeline optionality
Premium
The Fly
Scotiabank upgrades Argenx on Vyvgart upside, pipeline optionality
2M ago
Argenx upgraded to Outperform from Sector Perform at Scotiabank
Premium
The Fly
Argenx upgraded to Outperform from Sector Perform at Scotiabank
2M ago
Argenx price target raised to $665 from $585 at Guggenheim
PremiumThe FlyArgenx price target raised to $665 from $585 at Guggenheim
2M ago
Argenx price target raised to $688 from $605 at Raymond James
Premium
The Fly
Argenx price target raised to $688 from $605 at Raymond James
2M ago
Argenx price target raised to $646 from $560 at Oppenheimer
Premium
The Fly
Argenx price target raised to $646 from $560 at Oppenheimer
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100